{
    "title": "CANCER RESEARCH-Amgen drug extends survival in some inoperable colon cancers",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10886525/CANCER-RESEARCH-Amgen-drug-extends-survival-inoperable-colon-cancers.html",
    "date": "2022-06-05",
    "keywords": [
        "cancer",
        "drug",
        "survival",
        "treatment",
        "study",
        "trial",
        "colon",
        "leader",
        "dr",
        "standard",
        "cell",
        "myeloma",
        "stem",
        "transplant",
        "ifos",
        "nancy",
        "research",
        "vectibix",
        "side",
        "sunday",
        "antibody",
        "chemotherapy",
        "death",
        "interview",
        "care",
        "disease",
        "group",
        "threedrug",
        "protocol",
        "maintenance",
        "therapy",
        "tc",
        "june",
        "meeting",
        "society",
        "oncology",
        "asco",
        "gene",
        "httpsmeetingsascoorg2022ascoannualmeeting14416presentation208990208990",
        "class",
        "egfr",
        "wildtype",
        "average",
        "advantage",
        "risk",
        "surgery",
        "yoshino",
        "center",
        "hospital",
        "east",
        "kashiwa",
        "japan",
        "procedure",
        "httpsmeetingsascoorg2022ascoannualmeeting14416presentation213607213607",
        "half",
        "transplantation",
        "bristol",
        "revlimid",
        "rest",
        "option",
        "paul",
        "richardson",
        "farber",
        "institute",
        "boston",
        "reserve",
        "comparing",
        "highdose",
        "sarcoma",
        "year",
        "rate",
        "ninecountry",
        "eventfree",
        "time",
        "emergence",
        "versus",
        "mccabe",
        "university",
        "manchester",
        "editing",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}